6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2022

Commission File Number: 001-41089

Advanced Human Imaging Limited

(Translation of registrant’s name into English)

 71-73 South Perth Esplanade, Unit 5

South Perth, WA 6151

Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒             Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Attached as Exhibit 99.1 to this Report on Form 6-K is a copy of the press release of Advanced Human Imaging Limited, dated December 6, 2022: wellteq Acquisition Update – Consideration Shares Issued.

99.1 Press release dated December 6, 2022

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ADVANCED HUMAN IMAGING LIMITED
Date: December 7, 2022	By:	/s/ Scott Montgomery
		Name:	Scott Montgomery
		Title:	Chief Executive Officer

2

EX-99.1

Exhibit 99.1

ASX Announcement 6 December 2022  

wellteq Acquisition Update – Consideration Shares Issued

Advanced Human Imaging Ltd (ASX, NASDAQ: AHI) (AHI) refers shareholders to its announcement dated 2 September 2022 with respect to its proposed acquisition of wellteq Digital Health Inc (CSE:WTEQ) (OTCQB: WTEQF) (wellteq) by way of a plan of arrangement under the Business Corporations Act (British Columbia) (Transaction).

AHI is pleased to announce that it has issued 17,804,587 AHI fully paid ordinary shares in consideration for its acquisition of wellteq (Consideration Shares). The Consideration Shares have been issued to a depository and will be transferred to the wellteq shareholders once the Transaction becomes effective. It is expected that the Transaction will become effective at 12:01am (Vancouver time) on 6 December 2022.

AHI will release an announcement confirming once the Transaction becomes effective.

Further information with respect to wellteq, the Consideration Shares and the Transaction are set out in the ASX forms Appendix 2A and Appendix 3B released on the ASX today.

*This announcement has been approved by the board of Advanced Human Imaging Ltd.

For more information contact: 

Simon Durack Chief Financial Officer   Advanced Human Imaging Ltd  E: hello@ahi.tech     Vlado Bosanac   Head of Strategy  Advanced Human Imaging Ltd  E: hello@ahi.tech 

For more information please visit:  https://www.ahi.tech/  

Advanced Human Imaging Ltd

ACN 602 111 115

Postal Address: PO Box 190, South Perth WA 6951

Email: investors@ahi.tech